Contact
Please use this form to send email to PR contact of this press release:
Investors in Revance Therapeutics, Inc. Should Contact Levi & Korsinsky Before March 4, 2025 to Discuss Your Rights – RVNC
TO:
Please use this form to send email to PR contact of this press release:
Investors in Revance Therapeutics, Inc. Should Contact Levi & Korsinsky Before March 4, 2025 to Discuss Your Rights – RVNC
TO: